Literature DB >> 18355461

Fiat Lux: selective delivery of high flux of nitric oxide (NO) to biological targets using photoactive metal nitrosyls.

Michael J Rose1, Pradip K Mascharak.   

Abstract

In addition to its beneficial roles in blood pressure regulation, immune response, neurotransmission, and redox balance, nitric oxide (NO) can induce cellular apoptosis at relatively high concentrations. Since photoactive metal nitrosyls can deliver NO under the control of light, they are uniquely suited as NO drugs in photodynamic therapy (PDT) to destroy cancer cells. Stable and photoactive metal nitrosyls can first be placed in close proximity of a malignant site and then triggered via pulses of light to deliver high flux of NO. During the past few years, a number of such metal-based 'NO carriers' have been synthesized and tuned for rapid release of NO upon exposure to UV or visible light. Using various chromophore conjugation strategies, attempts are now being made to photosensitize the M-NO bond to infrared light. Progress has also been made in incorporating metal nitrosyls into biocompatible matrices for site-specific delivery of NO to tumors. A combination of light and NO could offer a viable treatment modality for cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18355461     DOI: 10.1016/j.cbpa.2008.02.009

Source DB:  PubMed          Journal:  Curr Opin Chem Biol        ISSN: 1367-5931            Impact factor:   8.822


  13 in total

Review 1.  Application of metal coordination chemistry to explore and manipulate cell biology.

Authors:  Kathryn L Haas; Katherine J Franz
Journal:  Chem Rev       Date:  2009-10       Impact factor: 60.622

2.  Near-Infrared Photoactivatable Nitric Oxide Donors with Integrated Photoacoustic Monitoring.

Authors:  Effie Y Zhou; Hailey J Knox; Christopher J Reinhardt; Gina Partipilo; Mark J Nilges; Jefferson Chan
Journal:  J Am Chem Soc       Date:  2018-09-10       Impact factor: 15.419

3.  Nitric oxide leads to cytoskeletal reorganization in the retinal pigment epithelium under oxidative stress.

Authors:  Srinivas R Sripathi; Weilue He; Ji-Yeon Um; Trevor Moser; Stevie Dehnbostel; Kimberly Kindt; Jeremy Goldman; Megan C Frost; Wan Jin Jahng
Journal:  Adv Biosci Biotechnol       Date:  2012

4.  Designed iron carbonyls as carbon monoxide (CO) releasing molecules: rapid CO release and delivery to myoglobin in aqueous buffer, and vasorelaxation of mouse aorta.

Authors:  Margarita A Gonzalez; Nicole L Fry; Richard Burt; Riddhi Davda; Adrian Hobbs; Pradip K Mascharak
Journal:  Inorg Chem       Date:  2011-03-08       Impact factor: 5.165

5.  Solid-phase synthesis as a platform for the discovery of new ruthenium complexes for efficient release of photocaged ligands with visible light.

Authors:  Rajgopal Sharma; Jessica D Knoll; Nicholas Ancona; Phillip D Martin; Claudia Turro; Jeremy J Kodanko
Journal:  Inorg Chem       Date:  2015-01-22       Impact factor: 5.165

6.  Bioinspired heme, heme/nonheme diiron, heme/copper, and inorganic NOx chemistry: *NO((g)) oxidation, peroxynitrite-metal chemistry, and *NO((g)) reductive coupling.

Authors:  Mark P Schopfer; Jun Wang; Kenneth D Karlin
Journal:  Inorg Chem       Date:  2010-07-19       Impact factor: 5.165

7.  Crystal structure of 1,1'-(pyridine-2,6-di-yl)bis-[N-(pyridin-2-ylmeth-yl)methanaminium] dichloride dihydrate.

Authors:  Layachi Merabet; Marine Tassé; Sonia Mallet-Ladeira; Lakhemici Kaboub; Isabelle Malfant
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2021-11-16

8.  Density functional theory calculations on Mössbauer parameters of nonheme iron nitrosyls.

Authors:  Kathrin H Hopmann; Abhik Ghosh; Louis Noodleman
Journal:  Inorg Chem       Date:  2009-10-05       Impact factor: 5.165

9.  Ruthenium nitrosyls derived from tetradentate ligands containing carboxamido-N and phenolato-o donors: syntheses, structures, photolability, and time dependent density functional theory studies.

Authors:  Nicole L Fry; Michael J Rose; David L Rogow; Crystal Nyitray; Manpreet Kaur; Pradip K Mascharak
Journal:  Inorg Chem       Date:  2010-02-15       Impact factor: 5.165

10.  Controlling Platinum, Ruthenium and Osmium Reactivity for Anticancer Drug Design.

Authors:  Pieter C A Bruijnincx; Peter J Sadler
Journal:  Adv Inorg Chem       Date:  2009-07-07       Impact factor: 3.282

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.